Original Article

Our Clinical Outcome: Patients With Benign Hematological Disease

  • S. Girgin
  • E. Gedik
  • B. Baç
  • H.İ. Taçyıldız

Received Date: 13.10.2008 Accepted Date: 14.10.2008 Eurasian J Emerg Med 2008;7(4):42-45


Surgical diseases of the spleen are most hematological diseases especially in patients with a severe refractory medical treatment. In this tstudy, we assessed our clinical experience patients with benign hematological disease clinical outcome of the disease processes requiring splenectomy.


A retrospective review of the 115 patients who had undergone splenectomy for hematological diseases was reveiwed. Age, gender, type of hematolojik disease, presence of accessory spleens and location, duration operation, Number of unit blood transfusion, length of hospital stay, long-term outcomes, morbidity and mortality were evaluated.


The mean age was 41.08±17.90 and, there were 67.8% female patients and 32.2% male patients. The most benign hematological disease which requiring splenectomy was idiopatic thrombocytopenic purpura (56.6%). The accessory spleens were encountered 26% patients during opration, and in six patients ,who operated for anemia, were underwent cholesystectomy. Complicatoin was occured 9.56% and the most complication was atelectasia. A patient was dieded from postsplenectomic sepsis.


Investigation of accessory spleens would not be missed to prevent the recurrences and in these patients anticoagulan profilaxy never be forgotten besides vaccination, and antibiotic profilaxy.

Keywords: Hematological disease, Splenectomy, Morbidity, Mortality